Article Text

Download PDFPDF

Editorial
  1. Jill Buyon1 and
  2. Ronald van Vollenhoven2
  1. 1NYU Langone Medical Center, New York, New York, USA
  2. 2The Karolinska Institute, Stockholm, Sweden
  1. Correspondence to Professor Jill Buyon; Jbuyonic{at}aol.com Dr Ronald van Vollenhoven; ronald.van.vollenhoven@ki.se

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Dear colleagues

It is with enormous pride and expectation that we introduce a brand new, open access, online journal devoted exclusively to lupus intended to provide a platform for basic, translational, epidemiological and clinical research: Lupus Science & Medicine. This medical-scientific journal, owned by the Lupus Foundation of America (LFA) and published by BMJ, the respected global provider of evidence-based medical knowledge, is now accepting submissions and its first publications are being processed.

Lupus Science & Medicine was first conceived in discussions that took place within the LFA. In addition to the myriad roles the Foundation plays in improving the lives of patients, they have now created a readily accessible home for lupus publications, an area that, until now, has been underserved to meet the rapidly evolving landscape of lupus pathogenesis and treatment. Open access publication …

View Full Text